224 related articles for article (PubMed ID: 27533245)
1. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
[TBL] [Abstract][Full Text] [Related]
2. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
[TBL] [Abstract][Full Text] [Related]
3. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; deFazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubiłski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; ; ; Pharoah PD; Gayther SA; Ness RB; Odunsi K; Sucheston LE; Knutson KL; Goode EL
Cancer Immunol Res; 2014 Apr; 2(4):332-40. PubMed ID: 24764580
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
5. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
Yoffou PH; Edjekouane L; Meunier L; Tremblay A; Provencher DM; Mes-Masson AM; Carmona E
PLoS One; 2011; 6(6):e20705. PubMed ID: 21695196
[TBL] [Abstract][Full Text] [Related]
6. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Phelan CM; Kuchenbaecker KB; Tyrer JP; Kar SP; Lawrenson K; Winham SJ; Dennis J; Pirie A; Riggan MJ; Chornokur G; Earp MA; Lyra PC; Lee JM; Coetzee S; Beesley J; McGuffog L; Soucy P; Dicks E; Lee A; Barrowdale D; Lecarpentier J; Leslie G; Aalfs CM; Aben KKH; Adams M; Adlard J; Andrulis IL; Anton-Culver H; Antonenkova N; ; Aravantinos G; Arnold N; Arun BK; Arver B; Azzollini J; Balmaña J; Banerjee SN; Barjhoux L; Barkardottir RB; Bean Y; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Birrer MJ; Bjorge L; Black A; Blankstein K; Blok MJ; Bodelon C; Bogdanova N; Bojesen A; Bonanni B; Borg Å; Bradbury AR; Brenton JD; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Bruinsma F; Brunet J; Buecher B; Butzow R; Buys SS; Caldes T; Caligo MA; Campbell I; Cannioto R; Carney ME; Cescon T; Chan SB; Chang-Claude J; Chanock S; Chen XQ; Chiew YE; Chiquette J; Chung WK; Claes KBM; Conner T; Cook LS; Cook J; Cramer DW; Cunningham JM; D'Aloisio AA; Daly MB; Damiola F; Damirovna SD; Dansonka-Mieszkowska A; Dao F; Davidson R; DeFazio A; Delnatte C; Doheny KF; Diez O; Ding YC; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dossus L; Duran M; Dürst M; Dworniczak B; Eccles D; Edwards T; Eeles R; Eilber U; Ejlertsen B; Ekici AB; Ellis S; Elvira M; ; Eng KH; Engel C; Evans DG; Fasching PA; Ferguson S; Ferrer SF; Flanagan JM; Fogarty ZC; Fortner RT; Fostira F; Foulkes WD; Fountzilas G; Fridley BL; Friebel TM; Friedman E; Frost D; Ganz PA; Garber J; García MJ; Garcia-Barberan V; Gehrig A; ; Gentry-Maharaj A; Gerdes AM; Giles GG; Glasspool R; Glendon G; Godwin AK; Goldgar DE; Goranova T; Gore M; Greene MH; Gronwald J; Gruber S; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harrington PA; Harris HR; Hauke J; ; Hein A; Henderson A; Hildebrandt MAT; Hillemanns P; Hodgson S; Høgdall CK; Høgdall E; Hogervorst FBL; Holland H; Hooning MJ; Hosking K; Huang RY; Hulick PJ; Hung J; Hunter DJ; Huntsman DG; Huzarski T; Imyanitov EN; Isaacs C; Iversen ES; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jernetz M; Jensen A; Jensen UB; John EM; Johnatty S; Jones ME; Kannisto P; Karlan BY; Karnezis A; Kast K; ; Kennedy CJ; Khusnutdinova E; Kiemeney LA; Kiiski JI; Kim SW; Kjaer SK; Köbel M; Kopperud RK; Kruse TA; Kupryjanczyk J; Kwong A; Laitman Y; Lambrechts D; Larrañaga N; Larson MC; Lazaro C; Le ND; Le Marchand L; Lee JW; Lele SB; Leminen A; Leroux D; Lester J; Lesueur F; Levine DA; Liang D; Liebrich C; Lilyquist J; Lipworth L; Lissowska J; Lu KH; Lubinński J; Luccarini C; Lundvall L; Mai PL; Mendoza-Fandiño G; Manoukian S; Massuger LFAG; May T; Mazoyer S; McAlpine JN; McGuire V; McLaughlin JR; McNeish I; Meijers-Heijboer H; Meindl A; Menon U; Mensenkamp AR; Merritt MA; Milne RL; Mitchell G; Modugno F; Moes-Sosnowska J; Moffitt M; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Nathanson KL; Nedergaard L; Ness RB; Neuhausen SL; Nevanlinna H; Niederacher D; Nussbaum RL; Odunsi K; Olah E; Olopade OI; Olsson H; Olswold C; O'Malley DM; Ong KR; Onland-Moret NC; ; Orr N; Orsulic S; Osorio A; Palli D; Papi L; Park-Simon TW; Paul J; Pearce CL; Pedersen IS; Peeters PHM; Peissel B; Peixoto A; Pejovic T; Pelttari LM; Permuth JB; Peterlongo P; Pezzani L; Pfeiler G; Phillips KA; Piedmonte M; Pike MC; Piskorz AM; Poblete SR; Pocza T; Poole EM; Poppe B; Porteous ME; Prieur F; Prokofyeva D; Pugh E; Pujana MA; Pujol P; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Rhiem K; Rice P; Richardson A; Robson M; Rodriguez GC; Rodríguez-Antona C; Romm J; Rookus MA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Salvesen HB; Sandler DP; Schoemaker MJ; Senter L; Setiawan VW; Severi G; Sharma P; Shelford T; Siddiqui N; Side LE; Sieh W; Singer CF; Sobol H; Song H; Southey MC; Spurdle AB; Stadler Z; Steinemann D; Stoppa-Lyonnet D; Sucheston-Campbell LE; Sukiennicki G; Sutphen R; Sutter C; Swerdlow AJ; Szabo CI; Szafron L; Tan YY; Taylor JA; Tea MK; Teixeira MR; Teo SH; Terry KL; Thompson PJ; Thomsen LCV; Thull DL; Tihomirova L; Tinker AV; Tischkowitz M; Tognazzo S; Toland AE; Tone A; Trabert B; Travis RC; Trichopoulou A; Tung N; Tworoger SS; van Altena AM; Van Den Berg D; van der Hout AH; van der Luijt RB; Van Heetvelde M; Van Nieuwenhuysen E; van Rensburg EJ; Vanderstichele A; Varon-Mateeva R; Vega A; Edwards DV; Vergote I; Vierkant RA; Vijai J; Vratimos A; Walker L; Walsh C; Wand D; Wang-Gohrke S; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; Whittemore AS; Wijnen JT; Wilkens LR; Wolk A; Woo M; Wu X; Wu AH; Yang H; Yannoukakos D; Ziogas A; Zorn KK; Narod SA; Easton DF; Amos CI; Schildkraut JM; Ramus SJ; Ottini L; Goodman MT; Park SK; Kelemen LE; Risch HA; Thomassen M; Offit K; Simard J; Schmutzler RK; Hazelett D; Monteiro AN; Couch FJ; Berchuck A; Chenevix-Trench G; Goode EL; Sellers TA; Gayther SA; Antoniou AC; Pharoah PDP
Nat Genet; 2017 May; 49(5):680-691. PubMed ID: 28346442
[TBL] [Abstract][Full Text] [Related]
7. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PD; ; ; ; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; deFazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1421-7. PubMed ID: 24740199
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Earp MA; Kelemen LE; Magliocco AM; Swenerton KD; Chenevix-Trench G; ; ; Lu Y; Hein A; Ekici AB; Beckmann MW; Fasching PA; Lambrechts D; Despierre E; Vergote I; Lambrechts S; Doherty JA; Rossing MA; Chang-Claude J; Rudolph A; Friel G; Moysich KB; Odunsi K; Sucheston-Campbell L; Lurie G; Goodman MT; Carney ME; Thompson PJ; Runnebaum IB; Dürst M; Hillemanns P; Dörk T; Antonenkova N; Bogdanova N; Leminen A; Nevanlinna H; Pelttari LM; Butzow R; Bunker CH; Modugno F; Edwards RP; Ness RB; du Bois A; Heitz F; Schwaab I; Harter P; Karlan BY; Walsh C; Lester J; Jensen A; Kjær SK; Høgdall CK; Høgdall E; Lundvall L; Sellers TA; Fridley BL; Goode EL; Cunningham JM; Vierkant RA; Giles GG; Baglietto L; Severi G; Southey MC; Liang D; Wu X; Lu K; Hildebrandt MA; Levine DA; Bisogna M; Schildkraut JM; Iversen ES; Weber RP; Berchuck A; Cramer DW; Terry KL; Poole EM; Tworoger SS; Bandera EV; Chandran U; Orlow I; Olson SH; Wik E; Salvesen HB; Bjorge L; Halle MK; van Altena AM; Aben KK; Kiemeney LA; Massuger LF; Pejovic T; Bean YT; Cybulski C; Gronwald J; Lubinski J; Wentzensen N; Brinton LA; Lissowska J; Garcia-Closas M; Dicks E; Dennis J; Easton DF; Song H; Tyrer JP; Pharoah PD; Eccles D; Campbell IG; Whittemore AS; McGuire V; Sieh W; Rothstein JH; Flanagan JM; Paul J; Brown R; Phelan CM; Risch HA; McLaughlin JR; Narod SA; Ziogas A; Anton-Culver H; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Wu AH; Pearce CL; Pike MC; Dansonka-Mieszkowska A; Rzepecka IK; Szafron LM; Kupryjanczyk J; Cook LS; Le ND; Brooks-Wilson A;
Hum Genet; 2014 May; 133(5):481-97. PubMed ID: 24190013
[TBL] [Abstract][Full Text] [Related]
9. The transforming growth factor-β receptor genes and the risk of intracranial aneurysms.
Ruigrok YM; Baas AF; Medic J; Wijmenga C; Rinkel GJ
Int J Stroke; 2012 Dec; 7(8):645-8. PubMed ID: 21978186
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
12. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
14. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
Permuth-Wey J; Chen YA; Tsai YY; Chen Z; Qu X; Lancaster JM; Stockwell H; Dagne G; Iversen E; Risch H; Barnholtz-Sloan J; Cunningham JM; Vierkant RA; Fridley BL; Sutphen R; McLaughlin J; Narod SA; Goode EL; Schildkraut JM; Fenstermacher D; Phelan CM; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1131-45. PubMed ID: 21447778
[TBL] [Abstract][Full Text] [Related]
15. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.
Sucheston-Campbell LE; Cannioto R; Clay AI; Etter JL; Eng KH; Liu S; Battaglia S; Hu Q; Szender JB; Minlikeeva A; Joseph JM; Mayor P; Abrams SI; Segal BH; Wallace PK; Soh KT; Zsiros E; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Bjorge L; Bruegl A; Campbell IG; Campbell SP; Chenevix-Trench G; Cramer DW; Dansonka-Mieszkowska A; Dao F; Diergaarde B; Doerk T; Doherty JA; du Bois A; Eccles D; Engelholm SA; Fasching PA; Gayther SA; Gentry-Maharaj A; Glasspool RM; Goodman MT; Gronwald J; Harter P; Hein A; Heitz F; Hillemmanns P; Høgdall C; Høgdall EV; Huzarski T; Jensen A; Johnatty SE; Jung A; Karlan BY; Klapdor R; Kluz T; Konopka B; Kjær SK; Kupryjanczyk J; Lambrechts D; Lester J; Lubiński J; Levine DA; Lundvall L; McGuire V; McNeish IA; Menon U; Modugno F; Ness RB; Orsulic S; Paul J; Pearce CL; Pejovic T; Pharoah P; Ramus SJ; Rothstein J; Rossing MA; Rübner M; Schildkraut JM; Schmalfeldt B; Schwaab I; Siddiqui N; Sieh W; Sobiczewski P; Song H; Terry KL; Van Nieuwenhuysen E; Vanderstichele A; Vergote I; Walsh CS; Webb PM; Wentzensen N; Whittemore AS; Wu AH; Ziogas A; Odunsi K; Chang-Claude J; Goode EL; Moysich KB;
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):420-424. PubMed ID: 27677730
[No Abstract] [Full Text] [Related]
16. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
[TBL] [Abstract][Full Text] [Related]
17. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
Amankwah EK; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Chornokur G; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chen Z; Chen YA; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Jim H; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston-Campbell L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Kelemen LE; Berchuck A; ; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
Genet Epidemiol; 2015 Dec; 39(8):689-97. PubMed ID: 26399219
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer risk associated with inherited inflammation-related variants.
White KL; Schildkraut JM; Palmieri RT; Iversen ES; Berchuck A; Vierkant RA; Rider DN; Charbonneau B; Cicek MS; Sutphen R; Birrer MJ; Pharoah PP; Song H; Tyrer J; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Phelan CM; Cunningham JM; Fridley BL; Sellers TA; Goode EL;
Cancer Res; 2012 Mar; 72(5):1064-9. PubMed ID: 22282663
[TBL] [Abstract][Full Text] [Related]
20. Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
Lowery WJ; Schildkraut JM; Akushevich L; Bentley R; Marks JR; Huntsman D; Berchuck A
Int J Gynecol Cancer; 2012 Jan; 22(1):9-14. PubMed ID: 22193641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
